Ada, Michigan – September 24, 2012– TransCorp Spine made its debut in Miami Beach, Florida at this year’s Annual Meeting of the Society for Minimally Invasive Spine Surgery (SMISS) showcasing its main product line, the SpinePort MIS Access System. The SpinePort system assists surgeons in performing the TransCorporeal MicroDecompression procedure in the cervical spine. “This year’s SMISS annual meeting was a great venue for us to introduce TransCorp Spine and our portfolio of products to minimally–‐invasive spine surgeons,” commented Chris Welch, President and CEO of TransCorp Spine. “With exposure to over 200 minimally–‐invasive spine surgeons this past weekend, we expect to get a running start with the commercialization of our SpinePort MIS Access System”. TransCorp Spine will continue to promote its SpinePort System and product portfolio at other spine conventions later this fall.
About TransCorp Spine, Inc. TransCorp Spine, Inc., founded in 2006 by Spine surgeons and engineers, is focused on developing innovative, minimally–‐invasive products and procedures that restore spinal function and preserve healthy tissue to set life back in motion for spine surgery patients. In 2012, TransCorp Spine received FDA clearance of its SpinePort MIS Access System. Continuing from this milestone achievement, TransCorp Spine is in the process of commercializing this innovative, minimally–‐invasive cervical spine access system. TransCorp Spine, Inc., is a well–‐ funded, privately–‐held, early–‐stage medical device company focused on bringing innovative spine surgery solutions to market that meet the needs of surgeons, improve the quality of life of patients and are cost effective for institutions and insurers. For more information, please visit our website at: http://www.transcorpspine.com.
Vice President, Marketing